Otilimab (Anti-CSF2 / GM-CSF)

Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2533
• Sku #: A2533-1mg*5